Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Schering-Plough Afrin, Lotrimin GMP Shortcomings Cited In FDA-483 Report

Jun 25 2001

• By The Tan Sheet

Related Content

Schering-Plough Reduced OTC Sales Forecast Due To GMP Problems

Feb 19 2001

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window